| SANDOZ GROUP AG SF -,05 |
| Schweiz |
| Gesundheit |
| CH1243598427 / A3ETYB |
| D8Y (Frankfurt) |
| FRA:D8Y, ETR:D8Y, D8Y:GR |
| - |
| https://www.sandoz.com/ |
|
Sandoz Group AG is a Swiss company specializing in generic pharmaceuticals and biosimilars. It serves as the global leader in providing affordable generic and biosimilar medicines, with a purpose centered on pioneering access to treatments for patien..
>Volltext.. |
| 31396.01 Mio. EUR |
| 34765.95 Mio. EUR |
| 9986.13 Mio. EUR |
| 1962.65 Mio. EUR |
| 819.63 Mio. EUR |
| 1.9 EUR |
| 4890.95 Mio. EUR |
| 1496.63 Mio. EUR |
| - |
| 0.25 |
| 1.78% |
| 28482.38% |
| 0.87 EUR |
| 1.23% |
| - |
| 13.04.26 - 0.8673081€ |
| - |
| SANDOZ |
| 21.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|